Trial Profile
Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Apr 2010
Price :
$35
*
At a glance
- Drugs Azimilide (Primary)
- Indications Arrhythmias
- Focus Therapeutic Use
- Sponsors Procter & Gamble
- 01 Apr 2010 New trial record